The United Kingdom-based family-owned investment company Richardson Family has also joined the round. Founded in 2020 in South Korea, injewelme utilises AI and data to develop preventive and personalised healthcare solutions.
A Singapore-based startup, injewelme , has raised $1.2 million in a funding round led by Temasek Trust’s catalytic vehicle, Catalytic Capital for Climate and Health.
The United Kingdom-based family-owned investment company Richardson Family has also joined the round.
Founded in 2020 in South Korea, injewelme utilises AI and data to develop preventive and personalised healthcare solutions. This includes its proprietary contactless health monitoring technology dubbed DeepHealthVision. It uses remote photoplethysmography to analyse more than 20 vital health parameters, such as blood pressure and oxygen saturation, in 30 seconds via a camera.
According to the startup, DHV demonstrated 95% detection accuracy in real-world pilots with SingHealth Polyclinics and private partners.
injewelme also develops the predictive AI, DeepHealthNet, which collects and analyses personal health data to predict changes and identify risks, and Gamified Health Management, an app for children and adolescents that gamifies health tracking.
Based on a media release, injewelme will use its fresh funds to develop further its contactless health monitoring technology by testing more parameters, such as blood glucose, stress index, fatigue, and hydration monitoring.
The new funds will also support efforts to acquire new customers in Singapore and expand into other markets across Southeast Asia.
The company has stated that DHV is now being evaluated for deployment across healthcare, eldercare, insurance, and workforce safety, including its use for monitoring physiological stress linked to rising climate-related heat exposure.
Stay tuned for more such updates on Digital Health News
Source link
